Irhythm Technologies Inc (IRTC)

$168.99 -10.44 (-5.82%)
Market Cap 5.78B
Revenue (ttm) 591.84M
Net Income (ttm) -113.29M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -19.14%
Debt to Equity Ratio 0.00
Volume 1,454,100
Avg Vol 495,702
Day's Range N/A - N/A
Shares Out 32.22M
Stochastic %K 35%
Beta 1.12
Analysts Strong Sell
Price Target $219.64

Company Profile

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG)...

Industry: Medical Devices
Sector: Healthcare
Phone: 415 632 5700
Address:
699 8th Street, Suite 600, San Francisco, United States
TICKERSPARK
TICKERSPARK Jan. 14 at 1:15 AM
iRhythm $IRTC hit 4x volume after management recalibrated guidance. Volume around a guidance reset rewrites the risk map.
0 · Reply
Okadarlan
Okadarlan Jan. 13 at 5:23 PM
$IRTC bankrupt in March 2027 @IjustTradeiT @DonCorleone77 mark it .
0 · Reply
BolsterBaron
BolsterBaron Dec. 26 at 8:23 AM
$IRTC Volatility reflects unresolved questions around how strategy converts into durable results. Forecast reliability will be tested repeatedly. Guidance slippage would be magnified by the market. Consistency will matter more than short-term excitement.
0 · Reply
TaxEfficientInvest
TaxEfficientInvest Dec. 25 at 3:57 PM
$IRTC Forward returns depend heavily on whether management can deliver consistent operational results. Cash flow visibility will determine how patient investors remain. A series of confirmed wins might reduce the required risk premium. Absent confirmation, volatility is likely to persist.
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Dec. 25 at 3:46 AM
$IRTC Massive volume increase with 822,600 shares traded on Dec 19, 2025, as price hit $174.17. Recent price range from $168.48 to $179.65. Smart money waits for lower H% before entering.
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Dec. 24 at 10:42 PM
Comparing trending tickers $IRTC vs $OPGN: IRTC is currently at $175.80, down by 1.49%, on a trading volume of 182.1K shares, which is below its average of 455.3K. On the other hand, OPGN has risen by 7.22%, reaching $15.00, with a volume of only 1.7K compared to its usual 8.1K. While OPGN has shown a significant price increase on relatively low volume, IRTC's price has declined despite a higher trading volume, albeit still below its average.
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Dec. 24 at 10:12 PM
Comparing trending tickers $GLSI vs $IRTC: GLSI is up 18.12% today, hitting $17.21 with a substantial volume increase to 461.8K shares, which is over 5 times its average volume. In contrast, IRTC is down 1.49% at $175.80, trading 181.2K shares, which is actually below its usual volume of 455.3K. Clearly, GLSI is experiencing a significant surge both in price and trading activity, whereas IRTC is seeing a dip in both its stock price and volume.
0 · Reply
JarvisFlow
JarvisFlow Dec. 24 at 7:35 PM
Oppenheimer has adjusted their stance on iRhythm Technologies ( $IRTC ), setting the rating to Outperform with a target price of 125 → 165.
0 · Reply
JarvisFlow
JarvisFlow Dec. 24 at 7:26 PM
Baird has adjusted their stance on iRhythm Technologies ( $IRTC ), setting the rating to Outperform with a target price of 126 → 133.
0 · Reply
JarvisFlow
JarvisFlow Dec. 24 at 7:24 PM
Baird updates rating for iRhythm Technologies ( $IRTC ) to Outperform, target set at 160 → 180.
0 · Reply
Latest News on IRTC
iRhythm Tech's Stock Selloff Went Too Far After Preliminary Update: Analyst

Jan 14, 2026, 12:43 PM EST - 3 hours ago

iRhythm Tech's Stock Selloff Went Too Far After Preliminary Update: Analyst

iRhythm Technologies, Inc. (IRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 1:46 PM EST - 2 days ago

iRhythm Technologies, Inc. (IRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 7:30 AM EST - 2 days ago

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference

iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 29, 2025, 4:30 PM EST - 15 days ago

iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 5, 2025, 2:25 PM EST - 5 weeks ago

HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 3, 2025, 3:53 PM EST - 6 weeks ago

iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC

Nov 13, 2025, 5:00 PM EST - 2 months ago

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC

iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025

Nov 11, 2025, 8:05 AM EST - 2 months ago

iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025

iRhythm: The Heart Monitor Maker Whose Stock Keeps Beating

Nov 5, 2025, 1:38 PM EST - 2 months ago

iRhythm: The Heart Monitor Maker Whose Stock Keeps Beating

iRhythm Technologies to Participate in Upcoming Investor Conferences

Nov 4, 2025, 4:30 PM EST - 2 months ago

iRhythm Technologies to Participate in Upcoming Investor Conferences

iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook

Oct 31, 2025, 2:17 PM EDT - 2 months ago

iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook

iRhythm Technologies, Inc. (IRTC) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 9:06 PM EDT - 2 months ago

iRhythm Technologies, Inc. (IRTC) Q3 2025 Earnings Call Transcript

iRhythm Technologies Announces Third Quarter 2025 Financial Results

Oct 30, 2025, 4:05 PM EDT - 2 months ago

iRhythm Technologies Announces Third Quarter 2025 Financial Results

Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 23, 2025, 5:00 PM EDT - 2 months ago

Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights

iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025

Oct 16, 2025, 4:30 PM EDT - 3 months ago

iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC

Sep 18, 2025, 1:30 PM EDT - 4 months ago

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC

IRhythm Technologies, Inc. (IRTC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 5:01 PM EDT - 4 months ago

IRhythm Technologies, Inc. (IRTC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service

Aug 29, 2025, 7:00 AM EDT - 4 months ago

AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service

Investor Short Report Flags Steep Downside Risk For iRhythm Technologies

Aug 18, 2025, 12:53 PM EDT - 5 months ago

Investor Short Report Flags Steep Downside Risk For iRhythm Technologies

AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority

Aug 18, 2025, 8:05 AM EDT - 5 months ago

AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority

iRhythm Technologies, Inc. (IRTC) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 9:49 PM EDT - 5 months ago

iRhythm Technologies, Inc. (IRTC) Q2 2025 Earnings Call Transcript

iRhythm Technologies Announces Second Quarter 2025 Financial Results

Jul 31, 2025, 4:05 PM EDT - 5 months ago

iRhythm Technologies Announces Second Quarter 2025 Financial Results

IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

Jul 25, 2025, 6:35 PM EDT - 6 months ago

IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025

Jul 17, 2025, 4:30 PM EDT - 6 months ago

iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

Jul 11, 2025, 10:12 PM EDT - 6 months ago

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

Jul 7, 2025, 8:30 AM EDT - 6 months ago

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease

Jun 23, 2025, 8:30 AM EDT - 7 months ago

New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation

Jun 17, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation

Jun 15, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jun 12, 2025, 10:00 AM EDT - 7 months ago

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect

Jun 10, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Connect

Jun 8, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Connect

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jun 5, 2025, 10:00 AM EDT - 7 months ago

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation

Jun 3, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Investors to Inquire about Securities Investigation

Jun 1, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Reach Out

May 29, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Reach Out

Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts

May 2, 2025, 1:24 PM EDT - 9 months ago

Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts

iRhythm Technologies, Inc. (IRTC) Q1 2025 Earnings Call Transcript

May 1, 2025, 9:14 PM EDT - 9 months ago

iRhythm Technologies, Inc. (IRTC) Q1 2025 Earnings Call Transcript

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

May 1, 2025, 4:10 PM EDT - 9 months ago

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

Apr 29, 2025, 6:05 PM EDT - 9 months ago

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

Apr 28, 2025, 8:05 AM EDT - 9 months ago

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

Apr 17, 2025, 4:30 PM EDT - 9 months ago

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

Apr 16, 2025, 8:35 AM EDT - 9 months ago

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

Mar 31, 2025, 8:05 AM EDT - 10 months ago

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

iRhythm Technologies, Inc. (IRTC) Q4 2024 Earnings Call Transcript

Feb 21, 2025, 12:23 AM EST - 11 months ago

iRhythm Technologies, Inc. (IRTC) Q4 2024 Earnings Call Transcript

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 20, 2025, 4:05 PM EST - 11 months ago

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect

Feb 14, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out

Feb 13, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Shareholders to Learn More About the Investigation

Feb 12, 2025, 10:00 AM EST - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Shareholders to Learn More About the Investigation

TICKERSPARK
TICKERSPARK Jan. 14 at 1:15 AM
iRhythm $IRTC hit 4x volume after management recalibrated guidance. Volume around a guidance reset rewrites the risk map.
0 · Reply
Okadarlan
Okadarlan Jan. 13 at 5:23 PM
$IRTC bankrupt in March 2027 @IjustTradeiT @DonCorleone77 mark it .
0 · Reply
BolsterBaron
BolsterBaron Dec. 26 at 8:23 AM
$IRTC Volatility reflects unresolved questions around how strategy converts into durable results. Forecast reliability will be tested repeatedly. Guidance slippage would be magnified by the market. Consistency will matter more than short-term excitement.
0 · Reply
TaxEfficientInvest
TaxEfficientInvest Dec. 25 at 3:57 PM
$IRTC Forward returns depend heavily on whether management can deliver consistent operational results. Cash flow visibility will determine how patient investors remain. A series of confirmed wins might reduce the required risk premium. Absent confirmation, volatility is likely to persist.
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Dec. 25 at 3:46 AM
$IRTC Massive volume increase with 822,600 shares traded on Dec 19, 2025, as price hit $174.17. Recent price range from $168.48 to $179.65. Smart money waits for lower H% before entering.
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Dec. 24 at 10:42 PM
Comparing trending tickers $IRTC vs $OPGN: IRTC is currently at $175.80, down by 1.49%, on a trading volume of 182.1K shares, which is below its average of 455.3K. On the other hand, OPGN has risen by 7.22%, reaching $15.00, with a volume of only 1.7K compared to its usual 8.1K. While OPGN has shown a significant price increase on relatively low volume, IRTC's price has declined despite a higher trading volume, albeit still below its average.
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Dec. 24 at 10:12 PM
Comparing trending tickers $GLSI vs $IRTC: GLSI is up 18.12% today, hitting $17.21 with a substantial volume increase to 461.8K shares, which is over 5 times its average volume. In contrast, IRTC is down 1.49% at $175.80, trading 181.2K shares, which is actually below its usual volume of 455.3K. Clearly, GLSI is experiencing a significant surge both in price and trading activity, whereas IRTC is seeing a dip in both its stock price and volume.
0 · Reply
JarvisFlow
JarvisFlow Dec. 24 at 7:35 PM
Oppenheimer has adjusted their stance on iRhythm Technologies ( $IRTC ), setting the rating to Outperform with a target price of 125 → 165.
0 · Reply
JarvisFlow
JarvisFlow Dec. 24 at 7:26 PM
Baird has adjusted their stance on iRhythm Technologies ( $IRTC ), setting the rating to Outperform with a target price of 126 → 133.
0 · Reply
JarvisFlow
JarvisFlow Dec. 24 at 7:24 PM
Baird updates rating for iRhythm Technologies ( $IRTC ) to Outperform, target set at 160 → 180.
0 · Reply
JarvisFlow
JarvisFlow Dec. 24 at 7:22 PM
Baird has updated their rating for iRhythm Technologies ( $IRTC ) to Outperform with a price target of 235.
0 · Reply
JarvisFlow
JarvisFlow Dec. 24 at 7:21 PM
Baird has updated their rating for iRhythm Technologies ( $IRTC ) to Outperform with a price target of 220.
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 4:14 PM
Truist Securities has adjusted their stance on iRhythm Technologies ( $IRTC ), setting the rating to Buy with a target price of 230 → 215.
0 · Reply
chlomo
chlomo Dec. 11 at 6:28 PM
$IRTC People, time to sell! BEAT announced a 12 lead ECG patch product. That is 12 times more information than IRTC patch can provide. BEAT has a market cap that is 1% of IRTC. Look for roles to reverse over next year or so!
0 · Reply
Ren_Stimpy
Ren_Stimpy Dec. 11 at 1:55 PM
$IRTC will need to buyout $BEAT to stay relevant in the cardiac monitoring business
0 · Reply
Maxwell_Osgood
Maxwell_Osgood Dec. 9 at 1:11 AM
$IRTC hmmmm... up or down? Not sure on this one... i might sell this tomorrow.
0 · Reply
magicshak
magicshak Dec. 7 at 7:17 PM
$IRTC One
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 5 at 10:59 PM
$IRTC Current Stock Price: $178.37 Contracts to trade: $180 IRTC Dec 19 2025 Call Entry: $4.30 Exit: $6.81 ROI: 58% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 5:45 PM
Morgan Stanley has adjusted their stance on iRhythm Technologies ( $IRTC ), setting the rating to Overweight with a target price of 195 → 205.
0 · Reply
Maxwell_Osgood
Maxwell_Osgood Nov. 23 at 12:47 AM
$IRTC yay!
0 · Reply
BillionerOfKing
BillionerOfKing Nov. 14 at 12:58 PM
$IRTC Current Stock Price: $168.52 Contracts to trade: $170 IRTC Nov 21 2025 Call Entry: $9.81 Exit: $12.99 ROI: 32% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
d_risk
d_risk Oct. 31 at 8:03 AM
$IRTC - iRhythm Technologies Inc. Common Stock - 10Q - Updated Risk Factors iRhythm’s latest 10-Q risk factors spotlight heavy reliance on Zio Services, shifting Medicare and reimbursement risks, expanded regulatory and compliance scrutiny, new supply chain and AI integration challenges, detailed IP and international expansion threats, increased debt exposure, and the removal of ESG and cybersecurity risk details. #HealthcareTechnology #IntellectualProperty #SupplyChainRisk #RegulatoryCompliance #MedicareReimbursement 🟢 Added 🟠 Removed https://d-risk.ai/IRTC/10-Q/2025-10-30
0 · Reply